Aberrant, noninfectious HIV-1 particles are released by chronically infected human T cells transduced with a retroviral vector expressing an interfering HIV-1 variant

The expression of the nonproducer F12-HIV-1 genome has been previously shown to protect the host cell from HIV superinfection. In order to estimate the efficacy of the F12-HIV genome as an anti-HIV reagent also in cells already infected, and HIV-1 chronically infected Hut-78 cell clone (D10) was superinfected with an amphotropic mouse/human pseudotype retrovirus whose genome expresses both the F12-HIV genome and the selection marker gene (ie the c-DNA of a truncated form of the nerve growth factor receptor, NGFr) under the control of F12-HIV BLTR. D10 cells homogenously expressing the F12-HIV genome (T-D10) released unaltered amounts of retrovirion whose infectivity was, however, dramatically impaired (from 9 x 10(3) in D10 to < 10(0.5) TCID50/ml in T-D10 supernatants). Electron microscopy showed that the morphology of retrovirions released by T-D10 cells was heavily altered, both in size and shape. Furthermore, no retrotranscription products were detectable in CD4(+) cells challenged with T-D10 retrovirions. For the first time, the block in the infectivity of HIV release from already infected cells through the expression of an anti-HIV retroviral vector was demonstrated. These data could have important implications both from a perspective of F-12-HIV-based anti-HIV gene therapy and, in general, on the role that nonproducer and/or defective HIV could play in vivo in HIV infection and AIDS pathogenesis.